DRAPER, Utah, Jan. 29, 2014 /PRNewswire/ -- Nutranomics,
Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company")
is pleased to provide this follow-up press release to highlight the
Company's on-going expansion strategy with business partner UNO
International Corp ("UNO"), a leading health and natural
products distributor and the largest multi-level marketing (MLM)
company in the Philippines.
Following Nutranomics CEO Tracy
Gibbs' visit to UNO headquarters and his subsequent speaking
engagement at the UNO Regional Convention held in December 2013 in Manila, UNO directors William Barbo, Oliver
Chua, and Herbie Chua visited
the corporate offices of Nutranomics in Draper, Utah, to meet with Dr. Gibbs and the
rest of the Nutranomics team. Discussions held at these
meetings led to a signed purchase order for a total of 20,000
bottles of a newly developed enzyme supplement and solidified plans
for additional product development.
Mr. William Barbo of UNO stated,
"UNO is the undisputed leading multi-level marketing firm in the
Philippines. In order to maintain that leadership position
and to be globally competitive, we standardize many business
procedures and partnering with Nutranomics for new product
development is one of the ways we accomplish this at UNO.
This is the main reason why UNO remains to be the only ISO
certified MLM company in the
Philippines over these many years. UNO is pleased to
be working with Dr. Gibbs and we know his products will boost our
exceptional product line-up significantly."
"At UNO, there are no special trade secrets, we just combine
having superior products while making them more affordable in the
market," added Oliver
Chua.
UNO International Corp. is the largest Philippines-based company engaged in the
direct and multi-level distribution of health enhancing natural
products and other services. As one of the pioneers and trend
setters in MLM over the last 8 years, UNO utilizes a dynamic reward
system and enhanced marketing plan designed to increase
competitiveness among distributors powered by a more attractive
compensation program. UNO has nearly 500,000 independent
distributors all over the globe. UNO currently operates in
Hong Kong, Macau, Singapore, United
Arab Emirates, and Kingdom of
Saudi Arabia. UNO is positioned to strengthen
its international reach with new offices planned to be opened soon
in the United States, United Kingdom, and Nigeria.
Dr. Gibbs concluded, "I am confident that we will be able to
build and maintain a long term relationship with UNO as they expand
into other countries around the world. With Nutranomics'
strength in R&D and UNO's obvious strengths in direct and
multi-level distribution, we can all greatly benefit from this
collaboration."
About Nutranomics
Nutranomics is a publicly traded company engaged in research and
development of nutritional food products. In 1997,
Nutranomics produced and branded its own product line, and began to
sell to the retail outlets and to the public. Nutranomics has
also produced formulas for hundreds of other companies.
Nutranomics' mission is to increase human health and longevity
through education and self-awareness. The Company has sales
representatives throughout North
America and Asia. Learn more about Nutranomics at
www.nutranomics.com.
For further information regarding Nutranomics, Inc., please
contact our investor relations representatives at
ir@nutranomics.com, or call toll-free (888) 616-3999.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements."
Statements in this press release that are not purely historical are
forward-looking statements and include any statements regarding
beliefs, plans, expectations or intentions regarding the
future. Actual results could differ from those projected in
any forward-looking statements due to numerous factors. Such
factors include, among others, the inherent uncertainties
associated with developing new products and operating as a
development stage company, our ability to raise the additional
funding we will need to continue to pursue our business and product
development plans, competition in the industry in which we operate
and market conditions. These forward-looking statements are
made as of the date of this news release, and we assume no
obligation to update the forward-looking statements, or to update
the reasons why actual results could differ from those projected in
the forward-looking statements, except as required by applicable
law, including the securities laws of the United States.
Although we believe that any beliefs, plans, expectations and
intentions contained in this press release are reasonable, there
can be no assurance that any such beliefs, plans, expectations or
intentions will prove to be accurate. Investors should
consult all of the information set forth herein and should also
refer to the risk factors disclosure outlined in the reports and
other documents we file with the SEC, available at
www.sec.gov. These statements have not been evaluated by the
Food and Drug Administration. These products are not intended
to diagnose, treat, cure or prevent any disease.
SOURCE Nutranomics, Inc.